<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(14)</volume><submitter>Slagboom T</submitter><journal>EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology</journal><pagination>1197-1200</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9936249</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.</pubmed_title><pmcid>PMC9936249</pmcid><pubmed_authors>Toelg R</pubmed_authors><pubmed_authors>Masotti M</pubmed_authors><pubmed_authors>Ruiz Salmeron R</pubmed_authors><pubmed_authors>Saito S</pubmed_authors><pubmed_authors>Slagboom T</pubmed_authors><pubmed_authors>Waksman R</pubmed_authors><pubmed_authors>Witzenbichler B</pubmed_authors><pubmed_authors>Witkowski AR</pubmed_authors><pubmed_authors>Takahashi A</pubmed_authors><pubmed_authors>Haude M</pubmed_authors><pubmed_authors>Uematus M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2026-06-01T23:46:09.539Z</modification><creation>2025-04-05T00:29:50.685Z</creation></dates><accession>S-EPMC9936249</accession><cross_references><pubmed>36625005</pubmed><doi>10.4244/eij-d-22-00526</doi><doi>10.4244/EIJ-D-22-00526</doi></cross_references></HashMap>